Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,087,703
-
Share change
-
-674,016
-
Total reported value
-
$14,838,993
-
Put/Call ratio
-
157%
-
Price per share
-
$3.63
-
Number of holders
-
22
-
Value change
-
-$3,209,332
-
Number of buys
-
9
-
Number of sells
-
14
Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q4 2020
As of 31 Dec 2020,
Protalix BioTherapeutics, Inc. - COM (PLX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,087,703 shares.
The largest 10 holders included
Burrage Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, UBS OCONNOR LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GROUP ONE TRADING, L.P., ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and JANE STREET GROUP, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.